These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 7302889

  • 1. Antithrombin III, the major modulator of intravascular coagulation, is synthesized by human endothelial cells.
    Chan TK, Chan V.
    Thromb Haemost; 1981 Aug 28; 46(2):504-6. PubMed ID: 7302889
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Formation of activated protein C and inactivation of cell-bound thrombin by antithrombin III at the surface of cultured vascular endothelial cells--a comparative study of two anticoagulant mechanisms.
    Delvos U, Meusel P, Preissner KT, Müller-Berghaus G.
    Thromb Haemost; 1987 Feb 03; 57(1):87-91. PubMed ID: 3590084
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
    Okajima K, Ueyama H, Hashimoto Y, Sasaki Y, Matsumoto K, Okabe H, Inoue M, Araki S, Takatsuki K.
    Thromb Haemost; 1989 Feb 28; 61(1):20-4. PubMed ID: 2749590
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thrombin-induced proteolysis of human antithrombin III: an outstanding contribution of heparin.
    Marciniak E.
    Br J Haematol; 1981 Jun 28; 48(2):325-36. PubMed ID: 7236529
    [Abstract] [Full Text] [Related]

  • 10. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
    Ofosu FA, Cerskus AL, Hirsh J, Smith LM, Modi GJ, Blajchman MA.
    Br J Haematol; 1984 Jun 28; 57(2):229-38. PubMed ID: 6733045
    [Abstract] [Full Text] [Related]

  • 11. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
    Tripodi A, Krachmalnicoff A, Mannucci PM.
    Thromb Haemost; 1986 Dec 15; 56(3):349-52. PubMed ID: 3563966
    [Abstract] [Full Text] [Related]

  • 12. Biochemical and functional study of antithrombin III in newborn infants.
    McDonald MM, Hathaway WE, Reeve EB, Leonard BD.
    Thromb Haemost; 1982 Feb 26; 47(1):56-8. PubMed ID: 7071806
    [Abstract] [Full Text] [Related]

  • 13. Practical considerations on the measurement of low molecular weight heparin anti-Xa activity.
    Aiach M, Roncato M.
    Semin Thromb Hemost; 1985 Apr 26; 11(2):108-11. PubMed ID: 4035362
    [No Abstract] [Full Text] [Related]

  • 14. Anticoagulant activity of artificial biomedical materials with co-immobilized antithrombin III and heparin.
    Miura Y, Aoyagi S, Ikeda F, Miyamoto K.
    Biochimie; 1980 Apr 26; 62(8-9):595-601. PubMed ID: 7417594
    [Abstract] [Full Text] [Related]

  • 15. The effect of a sulfated polysaccharide on antithrombin III.
    Czapek EE, Kwaan HC, Szczecinski M.
    J Lab Clin Med; 1980 Jun 26; 95(6):783-90. PubMed ID: 6155418
    [Abstract] [Full Text] [Related]

  • 16. Molecular weight of heparin versus biologic activity. Some additional considerations.
    Losito R, Losito C.
    Semin Thromb Hemost; 1985 Jan 26; 11(1):29-33. PubMed ID: 2579437
    [No Abstract] [Full Text] [Related]

  • 17. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J, von Pape KW, Blaurock M.
    Thromb Haemost; 1994 Mar 26; 71(3):280-3. PubMed ID: 8029789
    [Abstract] [Full Text] [Related]

  • 18. Homozygous variant of antithrombin III: AT III Fontainebleau.
    Boyer C, Wolf M, Vedrenne J, Meyer D, Larrieu MJ.
    Thromb Haemost; 1986 Aug 20; 56(1):18-22. PubMed ID: 3775688
    [Abstract] [Full Text] [Related]

  • 19. Pre-clinical pharmacological profile of the novel glycoconjugate Org 36764 with both factor Xa and thrombin (IIa) inhibitory activities.
    Vogel GM, van Amsterdam RG, van Dinther TG, Tromp M, Meuleman DG.
    Thromb Haemost; 2000 Oct 20; 84(4):611-20. PubMed ID: 11057859
    [Abstract] [Full Text] [Related]

  • 20. Expression and characterization of recombinant human antithrombin III in Pichia pastoris.
    Mochizuki S, Hamato N, Hirose M, Miyano K, Ohtani W, Kameyama S, Kuwae S, Tokuyama T, Ohi H.
    Protein Expr Purif; 2001 Oct 20; 23(1):55-65. PubMed ID: 11570846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.